Clinical Trial Update: Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study) [Phase 3]

View source ↗

Summary

Phase 3 Mojave study evaluating NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Meibomian Gland Dysfunction

Drugs mentioned

• NOV03

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-08-19